Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

I agree. It is likely we will receive several news items soon regarding Brilacidin:

1. Completed FDA 2b study data

2. FDA stage 3 plans for ABSSSI

3. Perhaps application for expedited study which would boost the share price, but since it is likely to be a short study may not make much practical difference.

4. Announcement of FDA plans for ophthalmic, otic and dermatologic Brilacidin studies.

5. I expect we will see an announcement regarding FDA study for other defensin-mimetics in the next few months. There is a critical need for new antibiotics for multiresistant gram negative infections and TB.The FDA should be anxious to facilitate these studies due the the high death rate of the hospital acquired gram negative infections and the positive pharmacologic and safety attributes of the first defensin-mimetic ,Brilacidin.